Selexis says KBI collaboration offers ‘gene to GMP’ in 10 months
Pelican Therapeutics has teamed with Selexis and sister CMO KBI Biopharma to advance two monoclonal antibody candidates.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs